Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 117-125, January 2010

White blood cell count and renin–angiotensin system inhibitors for the risk of cancer in type 2 diabetes

  • Xilin Yang

      Affiliations

    • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
    • Corresponding Author InformationCorresponding author at: Room 507, Li Ka Shing Institute of Health Sciences, c/o Department of Medicine and Therapeutics, The Prince of Wales Hospital, Shatin, Hong Kong, SAR, China. Tel.: +852 3763 6052; fax: +852 2637 3852.
    • ,
  • Ronald C.W. Ma

      Affiliations

    • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
    • ,
  • Wing Yee So

      Affiliations

    • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
    • ,
  • Gary T.C. Ko

      Affiliations

    • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
    • ,
  • Alice P.S. Kong

      Affiliations

    • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
    • ,
  • Hailu Zhao

      Affiliations

    • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
    • ,
  • Gang Xu

      Affiliations

    • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
    • ,
  • Peter C.Y. Tong

      Affiliations

    • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
    • Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
    • Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
    • ,
  • Juliana C.N. Chan

      Affiliations

    • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
    • Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
    • Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China

Received 12 May 2009; received in revised form 14 October 2009; accepted 22 October 2009. published online 23 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0168-8227(09)00460-4

doi:10.1016/j.diabres.2009.10.012

Refers to corrigendum:

  • Corrigendum to “White blood cell count and renin–angiotensin system inhibitors for the risk of cancer in type 2 diabetes” [Diabetes Res. Clin. Pract. 87 (1) (2010) 117–125] , 28 February 2011

    Xilin Yang, Ronald C.W. Ma, Wing Yee So, Gary T.C. Ko, Alice P.S. Kong, Hailu Zhao, Gang Xu, Peter C.Y. Tong, Juliana C.N. Chan
    Diabetes Research and Clinical Practice June 2011 (Vol. 92, Issue 3, Page 411)

Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 117-125, January 2010

Article Tools

* Image Usage & Resolution